Related Experiment Video
Updated: Jun 14, 2026
09:31
Characterization of Amyloid Structures in Aging C. Elegans Using Fluorescence Lifetime Imaging
Published on: March 27, 2020
Early detection of amyloid aggregation using intrinsic fluorescence
Olaf J Rolinski1, Mariana Amaro, David J S Birch
1Photophysics Group, Centre for Molecular Nanometrology, Department of Physics, Scottish Universities Physics Alliance, University of Strathclyde, 107 Rottenrow, Glasgow G4 0NG, UK. o.j.rolinski@strath.ac.uk
Biosensors & Bioelectronics
|April 6, 2010
Summary
Monitoring beta-amyloid (Abeta) aggregation via tyrosine fluorescence decay offers earlier Alzheimer's disease detection. This method detects changes before traditional Thioflavin T (ThT) intensity, aiding diagnosis and therapy development.
Area of Science:
- Biochemistry
- Neuroscience
- Medical Diagnostics
Background:
- Alzheimer's disease (AD) is linked to beta-amyloid (Abeta) plaque aggregation.
- Current diagnostic methods for Abeta aggregation, like Thioflavin T (ThT) fluorescence intensity, detect changes at later stages.
- Early detection of Abeta aggregation is crucial for timely intervention and effective treatment.
Purpose of the Study:
- To investigate the potential of intrinsic tyrosine fluorescence decay as an early marker for Abeta aggregation.
- To compare the sensitivity of tyrosine fluorescence decay with ThT fluorescence intensity in monitoring Abeta aggregation.
- To explore the implications of this finding for earlier Alzheimer's disease diagnosis and therapeutic development.
Main Methods:
- Utilizing intrinsic fluorescence decay measurements of tyrosine residues within Abeta.
- Monitoring Abeta aggregation processes over time.
- Comparing fluorescence decay alterations with traditional ThT fluorescence intensity measurements.
Main Results:
- Alterations in tyrosine fluorescence decay were observed to correlate with Abeta aggregation.
- These changes in tyrosine fluorescence decay were detectable at an earlier stage compared to ThT fluorescence intensity.
- The findings suggest tyrosine fluorescence decay is a more sensitive indicator of early Abeta aggregation.
Conclusions:
- Intrinsic tyrosine fluorescence decay is a promising early biomarker for Abeta aggregation.
- This technique may enable earlier diagnosis of Alzheimer's disease onset.
- The findings could lead to improved strategies for developing Alzheimer's intervention therapies.
